Back to search results
NCT06458998

Getting To Implementation: Improving Cancer Screening for Veterans

Enrolling by Invitation
NAAges 18+InterventionalHealth services
University of Pittsburgh
~30,300 participants
Updated 2026-07-31 on ClinicalTrials.gov
What's tested:Patient NavigationImplementation Facilitation

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in Reach of HCC screening from Baseline to 12 months
Measured over Baseline, 12 months from Baseline
+1 more outcome measured

Conditions

Cancer of Liver
Cancer of Colon
Cirrhosis

Explore related trials

CirrhosisColorectal CarcinomaHepatocellular Carcinoma

NCT06458998

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • VA Pittsburgh Healthcare System

    Pittsburgh, Pennsylvaniano site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Shari S Rogal, MD, MPH · PRINCIPAL_INVESTIGATOR · University of Pittsburgh

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

≥18 years of age
Enrolled in Veterans Health Administration (VA)
Have ≥1 VA encounter in the prior 18 months
Hepatocellular cancer (HCC) screening subgroup: Diagnosis of cirrhosis in electronic medical record
Colorectal cancer (CRC) screening subgroup: ≥45 years of age, positive fecal immunochemical test (FIT) (or other screening stool test) in the last 18 months 2. Providers:
Healthcare provider or related staff at participating VA site or engaged in CRC or HCC screening pathways in an included VA site (e.g., scheduling)
≥18 years of age

Exclusion

\<18 years of age
Not enrolled in VA
No VA encounters in the prior 18 months
Limited life expectancy (\< 6 months), defined as having a code for hospice 2. Providers:
Members of the study team will not participate, even if their sites are recruited

What this trial measures

  • Change in Reach of HCC screening from Baseline to 12 monthsBaseline, 12 months from Baseline

    Reach of an intervention refers to the absolute number, proportion, and representativeness of individuals who are willing to participate in a given intervention. The reach outcome will be the percentage of eligible Veterans in the HCC screening subgroup receiving guideline-concordant abdominal imaging within the prior 6 months.

  • Change in Reach of CRC screening from Baseline to 12 monthsBaseline, 12 months from Baseline

    Reach of an intervention refers to the absolute number, proportion, and representativeness of individuals who are willing to participate in a given intervention. The reach outcome will be the percentage of eligible Veterans in the CRC screening subgroup receiving a colonoscopy.